Erste Group Bank Lowers Earnings Estimates for Amgen Amid Recent Upgrades
Erste Group Bank has lowered its earnings estimates for Amgen Inc. (NASDAQ:AMGN) in a research report issued on August 5th. Analyst H. Engel now expects the medical research company to post earnings of $23.50 per share for FY2027, down from their previous estimate of $23.58.
The consensus estimate for Amgen's current full-year earnings is $22.78 per share. Despite this adjustment, several other analysts have raised their price targets and ratings on the stock. Weiss Ratings upgraded Amgen to a 'buy' rating in a recent research note, while Oppenheimer boosted its price objective from $400 to $450.
Amgen's latest quarterly earnings report exceeded expectations, with revenue of approximately $10.05 billion, up 9.5% year over year, and adjusted earnings of $6.29 per share surpassing the $5.62 consensus estimate.